📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
50-100%
- Net Income Growth Range (1Y):
25-50%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for V8Y
Quantum Healthcare Limited (V8Y)
Market: SGX |
Currency: SGD
Address: 745 Lorong 5 Toa Payoh
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. It operates through Vascular Business, Healthcare Business, Corporate segments. The Vascular Business segment engages in the development, manufacturing, and distribution of medical devices. Its Healthcare Business segments provides dental services. It also offers management consultancy services for healthcare organizations. The company was formerly known as QT Vascular Ltd. and changed its name to Quantum Healthcare Limited in July 2022. Quantum Healthcare Limited was founded in 2005 and is based in Singapore. The company operates as a subsidiary of Quantum Healthcare Limited.
Show more
📈 Quantum Healthcare Limited Historical Chart
🧾 Recent Financial Statement Analysis
January 28, 2026
Quantum Healthcare Limited EGM: Detailed Investor Report Quantum Healthcare Limited EGM: Major Share Issuances and Debt Conversion Approved Summary of Key Developments at the Extraordinary General Meeting Quantum Healthcare Limited held its Extraordinary General Meeting (EGM) on 29 December 2025,…
January 2, 2026
Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Key Points from the Announcement Completion of Major Corporate Actions: Quantum Healthcare Limited has announced the successful completion…
November 28, 2025
Quantum Healthcare Limited Completes Major Share Placement Quantum Healthcare Limited Completes S\$3 Million Share Placement – Major Expansion of Share Base Key Highlights Quantum Healthcare Limited has completed a substantial placement of 2,727,272,800 new ordinary shares. The placement raised an…
November 23, 2025
Key Developments Announced Quantum Healthcare Limited (“the Company”) has received a fresh Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the following proposed corporate actions: Placement of 2,727,272,800 New Ordinary Shares: The Company is…
November 13, 2025
Quantum Healthcare Limited Q3 2025 Financial Review: Improving Losses, Ongoing Uncertainty Quantum Healthcare Limited has released its unaudited condensed interim financial statements for the third quarter ended 30 September 2025. The company, which has shifted its focus primarily to dental…
October 6, 2025
Quantum Healthcare Announces Major Share Issuance, Debt Conversion and Directors’ Fee Capitalisation: What Investors Need to Know Quantum Healthcare Announces Massive Share Issuance, Debt-to-Equity Conversion, and Directors’ Fee Capitalisation SGX Approval Received: Significant Corporate Actions Signal Strategic Shift for Investors…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: V8Y, Quantum Healthcare Limited, Quantum Health, QUANH SP, QUANTUM HEALTHCARE LTD, QUANTUM HEALTHCARE
January 28, 2026
Quantum Healthcare Limited EGM: Detailed Investor Report Quantum Healthcare Limited EGM: Major Share Issuances and Debt Conversion Approved Summary of Key Developments at the Extraordinary General Meeting Quantum Healthcare Limited held its Extraordinary General Meeting (EGM) on 29 December 2025,…
January 2, 2026
Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Key Points from the Announcement Completion of Major Corporate Actions: Quantum Healthcare Limited has announced the successful completion…
November 28, 2025
Quantum Healthcare Limited Completes Major Share Placement Quantum Healthcare Limited Completes S\$3 Million Share Placement – Major Expansion of Share Base Key Highlights Quantum Healthcare Limited has completed a substantial placement of 2,727,272,800 new ordinary shares. The placement raised an…
November 23, 2025
Key Developments Announced Quantum Healthcare Limited (“the Company”) has received a fresh Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the following proposed corporate actions: Placement of 2,727,272,800 New Ordinary Shares: The Company is…
November 13, 2025
Quantum Healthcare Limited Q3 2025 Financial Review: Improving Losses, Ongoing Uncertainty Quantum Healthcare Limited has released its unaudited condensed interim financial statements for the third quarter ended 30 September 2025. The company, which has shifted its focus primarily to dental…
October 6, 2025
Quantum Healthcare Announces Major Share Issuance, Debt Conversion and Directors’ Fee Capitalisation: What Investors Need to Know Quantum Healthcare Announces Massive Share Issuance, Debt-to-Equity Conversion, and Directors’ Fee Capitalisation SGX Approval Received: Significant Corporate Actions Signal Strategic Shift for Investors…
September 25, 2025
Net Tangible Assets (NTA) per Share Before Placement After Placement After Placement, Debt Conversion & Fees Capitalisation NTA (S\$’000) (3,427) (427) (427) NTA per Share (Singapore cents) (0.043) (0.004) (0.003) Loss Per Share (LPS) Before Placement After Placement After Placement,…
September 22, 2025
Quantum Healthcare Faces Critical Funding and Debt Restructuring: Major Changes to Going Concern Status Could Impact Share Price Quantum Healthcare Faces Critical Funding and Debt Restructuring: Major Changes to Going Concern Status Could Impact Share Price Key Points from the…
September 22, 2025
Quantum Healthcare Launches Major Equity Deals: Placement, Debt Conversion & Directors’ Fee Capitalisation to Reshape Shareholding Structure Quantum Healthcare Launches Major Equity Deals: Placement, Debt Conversion & Directors’ Fee Capitalisation to Reshape Shareholding Structure Key Points Investors Must Know Quantum…
September 18, 2025
Quantum Healthcare Trading Halt Extended: What Investors Need to Know Ahead of Key Announcements Quantum Healthcare Trading Halt Extended: Critical Updates Pending for Investors Key Highlights from the Official Announcement Trading Halt Extension: Quantum Healthcare Limited has extended its trading…
September 18, 2025
Key Highlights from the Latest Announcement Quantum Healthcare Limited (QHL) remains under trading halt as of 18 September 2025. The trading halt was initially announced on 16 September 2025 and continues pending the finalisation of a further announcement by the…
